Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter

O. Pradier; K. Lederer; A. Hille; E. Weiss; H. Christiansen; H. Schmidberger; C. F. Hess

doi:10.1007/s00432-004-0633-0

Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-004-0633-0 ◽

2004 ◽

Vol 131 (4) ◽

pp. 261-269 ◽

Cited By ~ 18

Author(s):

O. Pradier ◽

K. Lederer ◽

A. Hille ◽

E. Weiss ◽

H. Christiansen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Special Reference ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Hemoglobin Level ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Phase II Trial of Daily Low-dose Carboplatin and Thoracic Radiotherapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyd022 ◽

2000 ◽

Vol 30 (2) ◽

pp. 59-64 ◽

Cited By ~ 29

Author(s):

S. Atagi

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Synchronized low-dose paclitaxel with timed thoracic radiotherapy (RT) followed by adjuvant chemotherapy (CT) with gemcitabine and carboplatin in stage III non-small cell lung cancer (NSCLC): Results of LJCC 07-01 phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e17507 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e17507-e17507

Author(s):

J. Zhang ◽

H. Gay ◽

S. M. Russo ◽

T. Parent ◽

P. R. Walker

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)

Annals of Oncology ◽

10.1093/annonc/mdz260.092 ◽

2019 ◽

Vol 30 ◽

pp. v646-v647 ◽

Cited By ~ 1

Author(s):

D. Heudobler ◽

C. Schulz ◽

J.R. Fischer ◽

P. Staib ◽

T. Wehler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Low Dose Chemotherapy

Download Full-text

Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7044 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7044-7044

Author(s):

J. Zhang ◽

S. M. Russo ◽

H. A. Gay ◽

T. Parent ◽

Z. Nelson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.395 ◽

2020 ◽

Vol 31 ◽

pp. S1399-S1400

Author(s):

S. Igawa ◽

R. Noro ◽

K. Kubota ◽

K. Naoki ◽

A. Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

Randomized phase II trial of tegafur-uracil (UFT) and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small cell lung cancer: NJLCG 0601.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7083 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7083-7083 ◽

Cited By ~ 1

Author(s):

M. Maemondo ◽

S. Sugawara ◽

T. Ishida ◽

A. Inoue ◽

K. Usui ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Unresectable Stage

Download Full-text

Abstract CT343: Phase II study of low-dose rate thoracic radiotherapy for treatment of intrathoracic relapsed or progressive small cell lung cancer

10.1158/1538-7445.am2014-ct343 ◽

2014 ◽

Author(s):

Guy C. Jones ◽

James B. Mitchell ◽

Bruce E. Johnson ◽

Kevin Camphausen ◽

Eli Glatstein ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Low Dose Rate

Download Full-text

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L

British Journal of Cancer ◽

10.1038/s41416-018-0243-2 ◽

2018 ◽

Vol 119 (6) ◽

pp. 675-682 ◽

Cited By ~ 11

Author(s):

Tomonari Sasaki ◽

Takashi Seto ◽

Takeharu Yamanaka ◽

Naonobu Kunitake ◽

Junichi Shimizu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2011.01.020 ◽

2011 ◽

Cited By ~ 2

Author(s):

Hamid Sheikh ◽

Rovel Colaco ◽

Paul Lorigan ◽

Fiona Blackhall ◽

Raffaele Califano ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Safety Data ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

70 Gy thoracic radiotherapy (TRT) is feasible concurrent with chemotherapy for limited stage small cell lung cancer (L-SCLC): preliminary analysis of a CALGB phase II trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(02)03234-0 ◽

2002 ◽

Vol 54 (2) ◽

pp. 103 ◽

Cited By ~ 5

Author(s):

J.A Bogart ◽

J.E Herndon ◽

A.P Lyss ◽

D Watson ◽

A.A Miller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Preliminary Analysis ◽

Phase Ii Trial ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Stage

Download Full-text